Insights into Company

Azad Engineering Limited

📍 Hyderabad, Telangana, India Active NSE AZAD CIN U74210TG1983PLC004132 Heavy Engineering & Capital Goods
Search companies

Key Metrics of Azad Engineering Limited

Revenue₹590 Cr▲ 30.3% YoYFY 2025-26
EBITDA₹265 Cr▲ 53.7% YoY
Net profit₹132 Cr▲ 49.3% YoY
Net worth₹1,552 Cr▲ 9.5% YoY
Competitors10identified

About Azad Engineering Limited

Sectors

Heavy Engineering & Capital GoodsMachine Tools & Industrial Machinery

Company details

Registered office
90/c,90/d, Phase 1 I.d.a, Jeedimetla, Hyderabad, In-ts, 500055
Listed
NSE: AZAD · ₹2,577.50

Operational Areas of Azad Engineering Limited

Heavy Engineering & Capital Goods›Machine Tools & Industrial Machinery

Company summary

Entity details

CINU74210TG1983PLC004132
LEI code3358006TNGEH6SXUN490
State codeTG
PIN code500055
Current legal nameAZAD ENGINEERING LIMITED
Classification—
Listing statusUnlisted
Registration no.004132
Company age—
PAN—
CountryIndia
CityHyderabad
StateTelangana
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code74210
Description of main activityOther business activities (consultancy, engineering, advertising, staffing)
Description of business activityOther business activities (consultancy, engineering, advertising, staffing)
SectorHeavy Engineering & Capital Goods · Machine Tools & Industrial Machinery
Premium

Financials, ratios and risk analysis

Revenue, EBITDA, net profit, net worth, debt and assets for every filing year, 15+ ratios, the financial health score, shareholding, charges and peer comparison are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 3 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 33 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Credit ratings

CARE · 22 Jun 2026 CARE A Stable outlook · Short term A2+ · Reaffirmed
Change in last 12 monthsNo change
Change since first rating on record▲ 2 notchessince Mar 2023
Rating actions71 up · 0 down
Liquidity (CARE)Adequate

Rating history

Rating actions

DateAgencyActionLong termShort termOutlookRated amountRationale
22 Jun 2026CAREReaffirmed AA2+Stable₹564 Cr View
06 Aug 2025CAREReaffirmed AA2+Stable₹248 Cr View
23 Jul 2025CAREUpgraded (from A-) A—Stable₹180 Cr View
07 Nov 2024CAREAssigned A-A2+Stable₹180 Cr View
22 Mar 2024CAREOther ———— View
07 Apr 2023CAREAssigned BBB+—Stable₹142 Cr View
03 Mar 2023CAREAssigned BBB+—Stable₹15.0 Cr View

Credit strengths (CARE, Jun 2026)

+ Experienced promoters and leadership team

Promoter Rakesh Chopdar brings over 27 years’ experience in the precision engineering industry. He has established strong relationships with customers through timely execution, consistent quality, and by securing relevant process certifications. The company’s operations are managed by a team of seasoned professionals, each with an average experience of over 18 years in their respective domains, having held key roles in reputed organisations such as Siemens, Godrej Aerospace, and Toshiba.

+ Consistent growth in revenue with healthy profitability margins

The company’s TOI registered a robust compound annual growth rate (CAGR) of 37.80% over five-years ending March 31, 2026, increasing from ₹123.12 crore in FY21 to ₹611.78 crore in FY26. This growth has been driven by the consistent supply of high- quality components and a strong focus on quality assurance. A significant portion of the company’s revenue is derived from exports, which yield superior profitability margins. As on March 31, 2026, the company has an outstanding order book of ₹6,500

+ Comfortable financial profile despite moderate leverage build-up

As on March 31, 2026, the company’s financial profile remains comfortable, with an overall gearing of 0.30x (PYE: 0.18x) and a debt-to-equity ratio of 0.22x (PYE: 0.14x). The increase in leverage in FY26 was primarily due to term loans availed for debt - funded capital expenditure. Despite the rise in debt, coverage indicators remain satisfactory on March 31, 2026, with total debt to gross cash accruals (TD/GCA) at 2.28x (PYE: 2.07x), PBILDT interest coverage ratio at 8.05x (PYE: 9.23x), and TOL

+ Presence in critical products of energy, aerospace, and oil and gas

The company manufactures airfoils used across the energy, defence, aerospace, and oil and gas sectors, where fail-safe performance is critical. Downtime of these turbines can result in disruptions to power transmission grids, making their reliability essential. These blades are produced from single-piece, high-grade metal alloys capable of withstanding extreme temperatures and pressures. AEL has developed the capability to supply such components consistently, maintaining high precision with tole

+ Established track record and advanced infrastructure

The company has an established manufacturing facility in Hyderabad and has been consistently expanding its capacity since FY18. The infrastructure currently includes a Forge Shop, Heat Treatment Shop, Hi -Tech CNC Machines, a state -of-the-art Laboratory and Inspection Facility, a Heavy Machining Shop, and advanced manufacturing software. It holds several international certifications, including National Aerospace and Defence Contractors Accreditation Program (NADCAP), ISO 9001:2015 (QMS),

Credit challenges

− Lengthy qualification process and commercialisation thereof

AEL serves the energy, aerospace, defence, and oil and gas sectors, industries characterised by lengthy and stringent qualification processes due to the critical nature of component applications. Each component must undergo rigorous validation, requiring sustained capital investment in product development and financial resilience to navigate the development phase. This process must be continuously undertaken to diversify the product portfolio and end-user sectors.

− Elongated working capital cycle

The company’s working capital cycle remained elongated at 344 days as on March 31, 2026, compared to 287 days in the previous year, primarily considering increased inventory holding period. The average inventory holding period rose to 262 days in FY26 from 209 days in FY25, driven by higher inventory requirements for products under development that involve customised alloys, which must be procured in bulk due to minimum order quantity constraints. In addition, inventory levels remained elevated

− Risk associated with large-sized debt-funded capex

The company has been augmenting its manufacturing capacity through the establishment of a new facility at Tuniki Bollaram, Hyderabad, in response to the full utilisation of its existing capacity. The new facility features well -segregated production areas designed to safeguard clients’ intellectual property rights. Given that AEL’s key customers account for a significant share of the global gas turbine manufacturing market, it is expected that the enhanced infrastructure strengthens customer con

Could lead to an upgrade

• Substantial improvement in scale of operations by leveraging newly added capacity while maintaining PBILDT margin at current level. • Sustained improvement in return on capital employed (ROCE) to above 20%, supported by efficient capital deployment and healthy profitability.

Could lead to a downgrade

• Inability to scale up operations and PBILDT margin falling below 30%. • Failing to improve operating cycle from current levels leading to further increase in reliance on working capital debt. • Significant weakening in the capital structure, reflected by total outstanding liabilities to tangible net worth (TOL/TNW) exceeding 0.5x.

Agency-reported financials (CARE, 22 Jun 2026)

MetricMarch 31, 2025March 31, 2026
Total operating income₹457 Cr₹612 Cr
PBILDT*₹166 Cr₹239 Cr
Profit after tax (PAT)₹88.53 Cr₹132 Cr
Overall gearing (x)0.18×0.30×
Interest coverage (x)9.23×8.05×
Revenue growth (YoY)—33.7%
PAT margin19.4%21.6%

Borrowings & rated debt

Rated borrowing limits (latest)₹564 Cr
Peak rated limits₹564 CrJun 2026 · CARE
Limits raised0 times6 new facilities rated

Rated limits over time

Facility mix

Rated facilities

FacilityTypePreviousCurrentChangeRatingActionAgency
Long-term bank facilitiesWorking capital & bank lines—₹337 Cr— A (Stable)ReaffirmedCARE
Long-term Short-term bank facilitiesWorking capital & bank lines—₹5.00 Cr— A / A2+ (Stable)AssignedCARE
Long-term Short-term bank facilitiesWorking capital & bank lines—₹200 Cr— A / A2+ (Stable)ReaffirmedCARE
Short-term bank facilitiesWorking capital & bank lines—₹22.9 Cr— A2+AssignedCARE

Debt instruments

ISINInstrumentTypeCouponIssuedMaturityAmountRatingStatus
——Debentures & bonds— 31 Mar 202331 Mar 2030 ₹0— Withdrawn

CARE ratings on record (checked 23 Oct 2026)

InstrumentAmountRating
Bank Guarantee₹5.00 CrCARE A; Stable / CARE A2+
Cash Credit—Withdrawn
Credit Exposure Limit₹22.9 CrCARE A2+
Non Convertible Debentures—Withdrawn
Packing Credit in Foreign Currency₹200 CrCARE A; Stable / CARE A2+
Proposed fund based limits—Withdrawn
Term Loan—Withdrawn
Term Loan₹337 CrCARE A; Stable

Lenders

Fund-based - LTTerm LoanBajaj Finance Ltd.
Fund-based - LTTerm LoanBandhan Bank Ltd.
Fund-based - LTTerm LoanHDFC Bank Ltd.
Fund-based - LTTerm LoanICICI Bank Ltd.
Fund-based - LTTerm LoanIndusInd Bank Ltd.
Fund-based - LTTerm LoanTata Capital Ltd.
Fund-based - LTTerm LoanUnion Bank of India
Fund-based - LTTerm LoanYes Bank Ltd.
Fund-based - LT/ STPacking Credit in Foreign CurrencyICICI Bank Ltd.
Fund-based - LT/ STPacking Credit in Foreign CurrencyIndusInd Bank Ltd.
Fund-based - LT/ STPacking Credit in Foreign CurrencyUnion Bank of India
Non-fund-based - LT/ STBank GuaranteeIndusInd Bank Ltd.
Non-fund-based - STCredit Exposure LimitICICI Bank Ltd.
Non-fund-based - STCredit Exposure LimitIndusInd Bank Ltd.

Credit assessment · Manufacturing

Rating Methodology – Manufacturing Companies (Mar 2025) · Standalone accounts · FY 2025-26

Indicative long-term—
Indicative short-term—
Score—
LiquidityStrongAgency: Adequate
DirectionStableAgency outlook: Stable
CARE rating · Jun 2026A3 notches below indicative

Ratios, pillar scores and the indicative rating are part of Premium.

Rating status

DefaultNo default on record
Issuer cooperationCooperating
Credit enhancementNone – standalone rating
Next action stable or better (model)81%
Information on file78% · missing: Capex / investment plans, Auditor details

Indicative assessment from public data using the published methodology factors; not a credit rating.

Borrowing & funding lifecycle

⬇ PDF report⬇ Excel
Can it borrow more?Further bank funding likely Next rating action stable or better: 68% (Mostly stable) · ML model on 4072 rating histories, AUC 0.666
Rated limits₹564 Cr
Not yet allocated—
Extra debt within 3.5× EBITDA—
Interest coverage8.05×
Limit utilisation68%
Open bank charges0 · —
  • Credit outlook model: 68% chance the next rating action is stable or better
  • Current rating A (investment grade)
  • Interest coverage 8.05×
  • Working-capital limits 68% utilised on average

Rated limits by facility

Timeline

22 Jun 2026 CARE reaffirmed: A (Stable)Rated limits ₹564.45 cr CARE rationale
22 Jun 2026 New borrowing arranged (term loans)
From the report

The increase in leverage in FY26 was primarily due to term loans availed for debt - funded capital expenditure.

CARE rationale
22 Jun 2026 Average working-capital utilisation 68%
From the report

Average utilisation of working capital limits stood at ~68% for the 12 months ended March 31, 2026, supported by a current ratio of 3.10x as on March 31, 2026.

CARE rationale
22 Jun 2026 Cash & liquid funds ₹183.58 cr
From the report

Free cash and liquid investment balance stood at ₹183.58 crore as on March 31, 2026.

CARE rationale
06 Aug 2025 CARE reaffirmed: A (Stable)Rated limits ₹248.32 cr CARE rationale
06 Aug 2025 ₹39.43 cr raised through term loans
From the report

The increase in leverage in FY25 was primarily due to term loans availed for debt-funded capital expenditure, which raised the total debt from ₹39.43 crore in FY24 to ₹25 6.99 crore in FY25.

CARE rationale
06 Aug 2025 New borrowing arranged: ₹39.43 cr (term loans)
From the report

The increase in leverage in FY25 was primarily due to term loans availed for debt-funded capital expenditure, which raised the total debt from ₹39.43 crore in FY24 to ₹25 6.99 crore in FY25.

CARE rationale
06 Aug 2025 ₹18.79 cr raised
From the report

The net proceeds amounted ₹681.21 crore after deducting fees, commissions, and issue-related expenses of ₹18.79 crore.

CARE rationale
06 Aug 2025 Average working-capital utilisation 84%
From the report

Average utilisation of working capital limits stood at a moderate ~84% for the 12 months ended May 31, 2025, supported by a strong current ratio of 5.00x as on March 31, 2025.

CARE rationale
06 Aug 2025 Cash & liquid funds ₹58.76 cr
From the report

The company maintained a robust cash and liquid investment balance of ₹58.76 crore as on March 31, 2024, which significantly increased to ₹695.62 crore as on March 31, 2025, primarily due to proceeds from issue of equity shares in FY25.

CARE rationale
23 Jul 2025 CARE upgraded: A (Stable)Rated limits ₹180 cr CARE rationale
23 Jul 2025 ₹39.43 cr raised through term loans
From the report

The increase in leverage in FY25 was primarily due to term loans availed for debt-funded capital expenditure, which raised the total debt from ₹39.43 crore in FY24 to ₹25 6.99 crore in FY25.

CARE rationale
23 Jul 2025 New borrowing arranged: ₹39.43 cr (term loans)
From the report

The increase in leverage in FY25 was primarily due to term loans availed for debt-funded capital expenditure, which raised the total debt from ₹39.43 crore in FY24 to ₹25 6.99 crore in FY25.

CARE rationale
23 Jul 2025 ₹18.79 cr raised
From the report

The net proceeds amounted ₹681.21 crore after deducting fees, commissions, and issue-related expenses of ₹18.79 crore.

CARE rationale
23 Jul 2025 Average working-capital utilisation 84%
From the report

Average utilisation of working capital limits stood at a moderate ~84% for the 12 months ended May 31, 2025, supported by a strong current ratio of 5.00x as on March 31, 2025.

CARE rationale
23 Jul 2025 Cash & liquid funds ₹58.76 cr
From the report

The company maintained a robust cash and liquid investment balance of ₹58.76 crore as on March 31, 2024, which significantly increased to ₹695.62 crore as on March 31, 2025, primarily due to proceeds from issue of equity shares in FY25.

CARE rationale
07 Nov 2024 CARE assigned: A- (Stable)Rated limits ₹180 cr CARE rationale
07 Nov 2024 New borrowing arranged: ₹139 cr (term loans)
From the report

However, overall gearing is projected to moderate in the medium term but remain below ~0.32x in FY25, considering newly sanctioned term loan of ₹139 crore and ₹35 crore of working capital borrowings.

CARE rationale
07 Nov 2024 Cash & liquid funds ₹58.76 cr
From the report

Liquidity: Adequate Liquidity is marked by strong accruals against repayment obligations of ₹9.91 crore and cash and cash equivalents of ₹58.76 crore on March 31, 2024 ( ₹39.99 crore on March 31, 2023).

CARE rationale
07 Nov 2024 Debt repayments due: ₹9.91 cr
From the report

Liquidity: Adequate Liquidity is marked by strong accruals against repayment obligations of ₹9.91 crore and cash and cash equivalents of ₹58.76 crore on March 31, 2024 ( ₹39.99 crore on March 31, 2023).

CARE rationale
07 Nov 2024 New borrowing arranged (equity)
From the report

Though the bank limits have been reduced by us ing IPO proceeds, the company availed fresh term loans and working capital borrowings in Q1FY25.

CARE rationale
22 Mar 2024 CARE other: — CARE rationale
07 Apr 2023 CARE assigned: BBB+ (Stable)Rated limits ₹142 cr CARE rationale
07 Apr 2023 Average working-capital utilisation 70%
From the report

Positive factors • Increase in scale of operations with total operating income (TOI) improving to ₹350 crore and above while maintaining profit before interest depreciation and tax (PBIDT) margin 30% on a sustained basis. • Improvement in liquidity position with average working capital utilization levels falling below 70% and operating cycle shortening to less than 150 days on a sustained basis.

CARE rationale
07 Apr 2023 Cash & liquid funds ₹67.38 cr
From the report

Liquidity: Strong Liquidity is marked by strong accruals against repayment obligations of ₹ 25 crore and cash & cash equivalents of ₹ 67.38 crore on December 31, 2022 (₹ 17.66 crore on March 31, 2022).

CARE rationale
07 Apr 2023 Debt repayments due: ₹25 cr
From the report

Liquidity: Strong Liquidity is marked by strong accruals against repayment obligations of ₹ 25 crore and cash & cash equivalents of ₹ 67.38 crore on December 31, 2022 (₹ 17.66 crore on March 31, 2022).

CARE rationale
07 Apr 2023 Cash & liquid funds ₹2 cr
From the report

Though the bank limits have bee n utilised to average of 95%, company has maintained minimum free cash of ₹ 2 crore in last 12 months ended January 31, 2023.

CARE rationale
03 Mar 2023 CARE assigned: BBB+ (Stable)Rated limits ₹15 cr CARE rationale
03 Mar 2023 Cash & liquid funds ₹67.38 cr
From the report

Liquidity: Strong Liquidity is marked by strong accruals against repayment obligations of ₹ 25 crore and cash & cash equivalents of ₹ 67.38 crore on December 31, 2022 (₹ 17.66 crore on March 31, 2022).

CARE rationale
03 Mar 2023 Debt repayments due: ₹25 cr
From the report

Liquidity: Strong Liquidity is marked by strong accruals against repayment obligations of ₹ 25 crore and cash & cash equivalents of ₹ 67.38 crore on December 31, 2022 (₹ 17.66 crore on March 31, 2022).

CARE rationale
03 Mar 2023 Cash & liquid funds ₹2 cr
From the report

Though the bank limits have been utilised to average of 95%, company has maintained minim um free cash of ₹ 2 crore in last 1 2 months ended January 31, 2023.

CARE rationale

Lender names, bank charges and audited borrowings are part of Premium.

Built from MCA charges, ICRA/CARE rating reports and audited accounts. The borrowing view is an estimate, not a lender's credit decision.

Registered office and contact

Registered office90/C,90/D, PHASE 1 I.D.A, JEEDIMETLA, HYDERABAD, IN-TS, 500055
GSTIN—
Email—
Website—
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of Azad Engineering Limited

Competitors10identified
Locations4most in India

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Larsen & Toubro Capital Goods & Power Equipment · Heavy Engineering & Capital Goods larsentoubro.com 1938 Mumbai, India
Thermax Capital Goods & Power Equipment · Heavy Engineering & Capital Goods thermaxglobal.com 1980 Pune, India
Blue Dart Express Outlets operated by Blue Dart Express. bluedart.com 1983 Mumbai, India
H.G. INFRA ENGINEERING LIMITED (PART IX) Machine Tools & Industrial Machinery · Heavy Engineering & Capital Goods — — Jodhpur, Rajasthan, India
Tata Hitachi Construction Machinery Company Machine Tools & Industrial Machinery · Heavy Engineering & Capital Goods tatahitachi.co.in — India
Kirloskar Brothers Capital Goods & Power Equipment · Heavy Engineering & Capital Goods kirloskarpumps.com 1888 Pune, India
SANSERA ENGINEERING LIMITED Machine Tools & Industrial Machinery · Heavy Engineering & Capital Goods sansera.in — Bangalore, Karnataka, India
Action Construction Equipment Limited Fertilisers, Seeds & Crop Protection · Agriculture & Agri-Inputs ace-cranes.com 2009 Palwal, India
AJAX Engineering Commercial Vehicles & Buses · Automobile Manufacturers ajax-engg.com 1992 Bangalore, India
IL&FS ENGINEERING AND CONSTRUCTION COMPANY LIMITED · Construction — — Hyderabad, Telangana, India

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Business activities and related parties

Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.

Filings

No filings on record yet.